Mitchell Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-27,555
Closed -$2.18M 149
2020
Q3
$2.18M Sell
27,555
-521
-2% -$40.8K 0.63% 53
2020
Q2
$2.07M Buy
28,076
+272
+1% +$20.5K 0.67% 52
2020
Q1
$2.04M Sell
27,804
-1,281
-4% -$101K 0.8% 43
2019
Q4
$2.52M Buy
29,085
+296
+1% +$24.3K 0.8% 42
2019
Q3
$2.31M Sell
28,789
-293
-1% -$23.5K 0.78% 40
2019
Q2
$2.33M Sell
29,082
-554
-2% -$42.4K 0.78% 38
2019
Q1
$2.35M Sell
29,636
-643
-2% -$48.1K 0.83% 37
2018
Q4
$2.21M Buy
+30,279
New +$2.14M 0.93% 32

Other funds holding MRK

Mitchell Capital Management's MRK Position: Q4 2020 in Review

Mitchell Capital Management sold out of Merck (MRK) in Q4 2020, closing a stake of 27,555 shares — an estimated $2.18M sold.

Mitchell Capital Management first reported a position in MRK in Q4 2018 and held it in 8 quarters. The position peaked at $2.52M in Q4 2019. 2,709 funds tracked by Wall St. Rank hold MRK as of Q4 2020.

  • Mitchell Capital Management reported no remaining Merck position as of Q4 2020 after selling out during the quarter.
  • Mitchell Capital Management sold 27,555 Merck shares in Q4 2020, an estimated $2.18M.
  • Mitchell Capital Management first reported a position in Merck in Q4 2018 and held it in 8 quarters.
  • Mitchell Capital Management's Merck position peaked at $2.52M in Q4 2019.
  • 2,709 funds tracked by Wall St. Rank held Merck as of Q4 2020.

Based on Mitchell Capital Management's 13F filing for Q4 2020, filed 8 Feb 2021.